Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM222B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | BUD13 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | SEC22B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | DEPDC4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | CYFIP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TCHHL1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | ART1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | CYP2S1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SENP2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | MESDC1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |